CVRx (CVRX) Net Margin Growth (1y) (2021 - 2026)
CVRx (CVRX) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn | 67.00 |
| 10 | CVRx | 75.83 Mn | 11.25 Mn | 13.72 Mn | 1,902.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,902.00 |
| Mar 31, 2026 | 2,265.00 |
| Dec 31, 2025 | -497.00 |
| Sep 30, 2025 | 1,034.00 |
| Jun 30, 2025 | 1,038.00 |
| Mar 31, 2025 | 9,451.00 |
| Dec 31, 2024 | 1,025.00 |
| Sep 30, 2024 | -1,222.00 |
| Jun 30, 2024 | 382.00 |
| Mar 31, 2024 | -6,345.00 |
| Dec 31, 2023 | 6,707.00 |
| Sep 30, 2023 | 7,318.00 |
| Jun 30, 2023 | 9,741.00 |
| Mar 31, 2023 | 10,257.00 |
| Dec 31, 2022 | 14,213.00 |
| Sep 30, 2022 | 2,174.00 |
| Jun 30, 2022 | 34,824.00 |
| Mar 31, 2022 | 5,653.00 |
| Dec 31, 2021 | -12,602.00 |
| Sep 30, 2021 | 14,302.00 |